Bolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical studies and results in the development of immunological memory, which may lead to more durable clinical responses for pa...
Add photos to showcase Bolt Biotherapeutics’s culture
Add Bolt Biotherapeutics’s values
Share your experience of working at Bolt Biotherapeutics
Add your teams to show how people work together at Bolt Biotherapeutics
Add jobs to your org chart to show candidates who they’ll work with
Publish company announcements to get more exposure